samedan logo
 
 
 
spacer
home > ebr > spring 2018 > data swap
PUBLICATIONS
European Biopharmaceutical Review

Data Swap

Biobanks play a significant role in the drug discovery process by providing researchers access to unique sample sets that can be linked to identifying characteristics, which, in turn, can accurately diagnose disease and predict drug response.

Today’s research biobank typically provides physical sample storage and maintains associated data within their databases. Information about acquisition, quality, state, location, processing outcomes, quantity, and usage are all generally available at a minimum, but are primarily focused on the sample characteristics. However, researchers want to link individualities to attributes of the donor, including phenotypical, demographical, genetic, or lifestyle attributes.

A challenge can present itself between the biobank resources and requirements of the research community. The types and amount of data linked to the physical sample that is needed to identify pertinent information can grow more important and complex. Therefore, meeting the expanding specificity of research programmes requires each sample within a biorepository to be connected to as comprehensive a data array as possible to deliver maximum value.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Thurston is Director of Informatics at Brooks Life Sciences, having joined the company in 2015. He has worked in the field of laboratory informatics for over 20 years and has experience in the development, sales, support and marketing of a variety of laboratory software. A graduate of Salford University, UK, with a BSc in chemistry, Colin began his career researching solid-state secondary lithium batteries.
spacer
Colin Thurston
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals

[Pamplona, November 26 2019] 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, a UK based Biotech company, to collaborate in the development of a novel anti-tumour treatment.
More info >>

White Papers

How to Reduce Costs of Specialty Pharmaceutical Shipments and Increase Patient Satisfaction

Temptime Corporation

The specialty pharmacy industry could reduce costs by $27.5 million annually (product and call center staff costs only) if visual temperature indicators were used as decision-making tools to determine if medicine should be used or returned when patients suspect heat damage. In addition, 97% of patients surveyed, who received medicine from specialty pharmacies with a visual temperature indicator included in the package, agree that they would want an indicator in all shipments and 95% agree the indicator increased their confidence in the medicines received.
More info >>

 
Industry Events

BIO-Europe Digital

26-29 October 2020, Digitally delivered

Global connections are more important than ever. With the same powerful one-to-one partnering and valuable content, BIO-Europe Digital continues to help you drive your life science partnering forward.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement